These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29385580)

  • 1. Patient communication of cancer genetic test results in a diverse population.
    Ricker CN; Koff RB; Qu C; Culver J; Sturgeon D; Kingham KE; Lowstuter K; Chun NM; Rowe-Teeter C; Lebensohn A; Levonian P; Partynski K; Lara-Otero K; Hong C; Petrovchich IM; Mills MA; Hartman AR; Allen B; Ladabaum U; McDonnell K; Ford JM; Gruber SB; Kurian AW; Idos GE
    Transl Behav Med; 2018 Jan; 8(1):85-94. PubMed ID: 29385580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.
    Culver JO; Ricker CN; Bonner J; Kidd J; Sturgeon D; Hodan R; Kingham K; Lowstuter K; Chun NM; Lebensohn AP; Rowe-Teeter C; Levonian P; Partynski K; Lara-Otero K; Hong C; Morales Pichardo J; Mills MA; Brown K; Lerman C; Ladabaum U; McDonnell KJ; Ford JM; Gruber SB; Kurian AW; Idos GE
    Cancer; 2021 Apr; 127(8):1275-1285. PubMed ID: 33320347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.
    Chopra I; Kelly KM
    J Health Commun; 2017 Feb; 22(2):143-152. PubMed ID: 28112991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How families communicate about HNPCC genetic testing: findings from a qualitative study.
    Peterson SK; Watts BG; Koehly LM; Vernon SW; Baile WF; Kohlmann WK; Gritz ER
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):78-86. PubMed ID: 12704641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort.
    Ricker C; Culver JO; Lowstuter K; Sturgeon D; Sturgeon JD; Chanock CR; Gauderman WJ; McDonnell KJ; Idos GE; Gruber SB
    Cancer Genet; 2016 Apr; 209(4):130-7. PubMed ID: 26908360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial and Clinical Factors Associated with Family Communication of Cancer Genetic Test Results among Women Diagnosed with Breast Cancer at a Young Age.
    Elrick A; Ashida S; Ivanovich J; Lyons S; Biesecker BB; Goodman MS; Kaphingst KA
    J Genet Couns; 2017 Feb; 26(1):173-181. PubMed ID: 27422778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and Ethnic Disparities in Genomic Healthcare Utilization, Patient Activation, and Intrafamilial Communication of Risk among Females Tested for
    Hesse-Biber S; Seven M; Shea H; Heaney M; Dwyer AA
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.
    Flores KG; Steffen LE; McLouth CJ; Vicuña BE; Gammon A; Kohlmann W; Vigil L; Dayao ZR; Royce ME; Kinney AY
    J Genet Couns; 2017 Jun; 26(3):480-490. PubMed ID: 27496122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening.
    Frey MK; Kim SH; Bassett RY; Martineau J; Dalton E; Chern JY; Blank SV
    Gynecol Oncol; 2015 Nov; 139(2):211-5. PubMed ID: 26296696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
    Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
    J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to Mental Health Care for an Ethnically and Racially Diverse Sample of Older Adults.
    Sorkin DH; Murphy M; Nguyen H; Biegler KA
    J Am Geriatr Soc; 2016 Oct; 64(10):2138-2143. PubMed ID: 27565017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family communication of cancer genetic test results in an ethnically diverse population: a qualitative exploration of more than 200 patients.
    Hodan R; Picus M; Stanclift C; Ormond KE; Pichardo JM; Kurian AW; Ricker C; Idos GE
    J Community Genet; 2024 Aug; 15(4):363-374. PubMed ID: 38814439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
    Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial and ethnic disparities in awareness of genetic testing for cancer risk.
    Pagán JA; Su D; Li L; Armstrong K; Asch DA
    Am J Prev Med; 2009 Dec; 37(6):524-30. PubMed ID: 19944919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.